We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Brain Cancer

Journal Scan / Research · June 10, 2021

Prognostic Significance of Genome-Wide DNA Methylation Profiles in Non–1p/19q-Deleted Anaplastic Glioma

Neuro-oncology

 

Additional Info

Neuro-oncology
Prognostic Significance of Genome-Wide DNA Methylation Profiles Within the Randomised, Phase 3, EORTC CATNON Trial on Non-1p/19q Deleted Anaplastic Glioma
Neuro-oncology 2021 Apr 29;[EPub Ahead of Print], CMS Tesileanu, MJ van den Bent, M Sanson, W Wick, AA Brandes, PM Clement, SC Erridge, MA Vogelbaum, AK Nowak, JF Baurain, WP Mason, H Wheeler, OL Chinot, S Gill, M Griffin, L Rogers, W Taal, R Rudà, M Weller, C McBain, ME van Linde, TS Sabedot, Y Hoogstrate, A von Deimling, I de Heer, WFJ van IJcken, RWW Brouwer, K Aldape, RB Jenkins, HJ Dubbink, JM Kros, P Wesseling, KJ Cheung, V Golfinopoulos, BG Baumert, T Gorlia, H Noushmehr, PJ French

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading